Oxaliplatin in Treating Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This phase 0/II trial studies the effect of carbon C 14 oxaliplatin in tumor tissue and blood
and the side effects and how well oxaliplatin works in treating patients with metastatic
breast cancer. DNA analysis of tumor tissue and blood samples from patients receiving carbon
C 14 oxaliplatin may help doctors predict how well patients will respond to treatment with
oxaliplatin. Drugs used in chemotherapy, such as oxaliplatin, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.